Business
Celyad Oncology SA: Publication of a Transparency Notification Received from Fortress Investment Group LLC
MONT-SAINT-GUIBERT, Belgium, August 13, 2025--Regulatory News: Celyad Oncology SA (Euronext: CYAD) ("Celyad Oncology" or the "Company") today announces, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major shareholdings in issuers whose securities are admitted to trading on a regulated market (the "Transparency Law"), that it received a notification of transparency dated August 11, 2025, indicating that CFIP CLYD (UK) Limited, an affiliate of Fortress
About this update from Celyad Oncology Sa
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/fd8531b344a5cee1b201c78e535e70a4"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/hSiXE6Lh_UmUiEb_1j8hJA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/fd8531b344a5cee1b201c78e535e70a4","width":960,"height":480},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/6KqtdDAI3_iY0eZqqqyfRw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0O2NmPXdlYnA-/https://media.zenfs.com/en/business-wire.com/fd8531b344a5cee1b201c78e535e70a4","width":1024,"height":512}},"lazy":false},{"type":"text","content":"(Article 14 §1 of the Law of 2 May 2007)","length":40,"tagName":"p","attribs":{}},{"type":"text","content":"MONT-SAINT-GUIBERT, Belgium, August 13, 2025--(BUSINESS WIRE)--Regulatory News:","length":79,"tagName":"p"},{"type":"text","content":"Celyad Oncology SA (Euronext: CYAD) ("Celyad Oncology" or the "Company") today announces, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major shareholdings in issuers whose securities are admitted to trading on a regulated market (the "Transparency Law"), that it received a notification of transparency dated August 11, 2025, indicating that CFIP CLYD (UK) Limited, an affiliate of Fortress Investment Group LLC, has crossed the statutory threshold of 60%, holding 32,691,987 voting rights, i.e. 60.96% of Celyad Oncology’s voting rights.","length":615,"tagName":"p"},{"type":"text","content":"Content of the Notification:","length":28,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Reason of the Notification:Acquisition or disposal of voting securities or voting rights","length":89,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":89,"olType":false},{"type":"list","items":[{"val":[{"type":"text","content":"Notification by:A parent undertaking or a controlling person","length":61,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":61,"olType":false},{"type":"list","items":[{"val":[{"type":"text","content":"Persons subject to the notification requirement:Fortress Investment Group LLC - 1345 Avenue of the Americas, New York,...